Luvira V, Lawpoolsri S, Phumratanaprapin W, Jongkaewwattana A, et al. Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S). Vaccine 2025;62:127601.
PMID: 40789265